ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -80.0% | 7 | -93.9% | 0.00% | – |
Q2 2021 | $5,000 | -99.6% | 115 | -99.6% | 0.00% | -100.0% |
Q1 2021 | $1,356,000 | -51.2% | 27,491 | -58.3% | 0.00% | -50.0% |
Q4 2020 | $2,779,000 | -21.7% | 66,004 | -14.9% | 0.01% | -25.0% |
Q3 2020 | $3,550,000 | -8.3% | 77,549 | +0.6% | 0.01% | -20.0% |
Q2 2020 | $3,871,000 | +196.6% | 77,104 | +203.9% | 0.01% | +150.0% |
Q1 2020 | $1,305,000 | +14400.0% | 25,371 | +17766.9% | 0.00% | – |
Q4 2019 | $9,000 | -98.2% | 142 | -98.3% | 0.00% | -100.0% |
Q3 2019 | $497,000 | -28.5% | 8,273 | +0.4% | 0.00% | -50.0% |
Q2 2019 | $695,000 | -32.9% | 8,236 | -24.1% | 0.00% | -33.3% |
Q1 2019 | $1,036,000 | -65.7% | 10,846 | -74.5% | 0.00% | -62.5% |
Q4 2018 | $3,018,000 | -37.3% | 42,607 | -24.4% | 0.01% | -27.3% |
Q3 2018 | $4,814,000 | -38.5% | 56,332 | -16.6% | 0.01% | -52.2% |
Q2 2018 | $7,829,000 | +195625.0% | 67,552 | +132354.9% | 0.02% | – |
Q1 2018 | $4,000 | -50.0% | 51 | -79.6% | 0.00% | – |
Q1 2017 | $8,000 | -46.7% | 250 | -45.7% | 0.00% | – |
Q4 2016 | $15,000 | -96.1% | 460 | -96.3% | 0.00% | -100.0% |
Q1 2015 | $386,000 | -68.5% | 12,591 | -47.8% | 0.00% | -75.0% |
Q4 2014 | $1,226,000 | +32.3% | 24,112 | +2.9% | 0.00% | +33.3% |
Q3 2014 | $927,000 | +11487.5% | 23,429 | +13062.4% | 0.00% | – |
Q2 2014 | $8,000 | – | 178 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |